Please check your internet connection and try again.
# Hyaluronic Acid
## Overview
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan that functions as a viscoelastic agent and a lubricant. It is available in various formulations for different routes of administration.
## Primary Indications
* **Intra-articular injection:** Osteoarthritis of the knee.
* **Ophthalmic solution:** Ocular lubrication for dry eye disease; adjunct in ophthalmic surgery.
* **Topical:** Wound healing, skin hydration.
* **Intravenous (less common, specialized):** Osteoarthritis (off-label, varying evidence).
## Adult Dosing
* **Osteoarthritis of the knee (intra-articular):** Typically 2 mL (20 mg) injected intra-articularly once weekly for 3 weeks (e.g., Synvisc-One® is 6 mL (48 mg) given as a single injection). Specific product and regimen vary; follow manufacturer's recommendations.
* **Dry eye disease (ophthalmic solution):** Typically 1 drop in each eye every 6 to 8 hours or as needed. Concentration varies by product (e.g., 0.2%, 0.4%).
* **Ophthalmic surgery (viscoelastic):** Administered by the surgeon during the procedure. Dose and volume are procedure-dependent.
* **Topical:** Varies widely by product and indication. Follow product labeling.
## Pediatric Dosing
Established pediatric dosing for intra-articular or ophthalmic indications is generally not available or is based on limited data. Use with caution and consider extrapolation from adult data or specialist consultation.
## Dose Adjustments
No specific dose adjustments are generally required for hepatic or renal impairment, as HA is not systemically metabolized or renally excreted to a significant extent.
## Contraindications
* Known hypersensitivity to hyaluronic acid or any component of the formulation.
* Infection at or near the injection site for intra-articular injections.
* Severe skin infections or inflammatory conditions over the injection area for intra-articular injections.
## Adverse Effects
* **Intra-articular:** Pain, swelling, stiffness, warmth, or redness at the injection site. Infrequently, joint effusion, arthralgia, or hypersensitivity reactions.
* **Ophthalmic:** Temporary blurred vision, eye irritation, stinging, redness.
* **Topical:** Localized skin irritation.
## Key Drug Interactions
No significant drug interactions are generally reported for intra-articular or topical formulations. Systemic absorption is minimal.
## Monitoring
* **Intra-articular:** Monitor for signs of local infection or inflammatory reaction at the injection site. Assess for symptom relief.
* **Ophthalmic:** Monitor for symptom relief of dry eye. Assess for signs of ocular irritation.
## Clinical Pearls
* For intra-articular use, it is crucial to differentiate between various HA products (e.g., single-injection vs. multi-injection regimens) as the molecular weight and cross-linking can differ, influencing dosing.
* Avoid strenuous activity for 24-48 hours following intra-articular injection.
* For ophthalmic use, advise patients to avoid touching the dropper tip to any surface and to wait several minutes between administering different ophthalmic drops.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for definitive patient care decisions. Dosing and indications may vary based on specific product formulations and local protocols.
